SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001213900-21-045917
Filing Date
2021-08-31
Accepted
2021-08-31 16:59:27
Documents
8

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea146407-s1_180lifesciences.htm S-1 2884162
2 OPINION OF PRYOR CASHMAN LLP ea146407ex5-1_180lifescience.htm EX-5.1 15651
3 CONSENT OF MARCUM LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM. ea146407ex23-1_180lifesci.htm EX-23.1 2436
4 GRAPHIC image_001.jpg GRAPHIC 105237
5 GRAPHIC image_002.jpg GRAPHIC 53102
6 GRAPHIC image_003.jpg GRAPHIC 18163
7 GRAPHIC image_004.jpg GRAPHIC 41661
8 GRAPHIC ex5-1_001.jpg GRAPHIC 27227
  Complete submission text file 0001213900-21-045917.txt   3241893
Mailing Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025
Business Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

IRS No.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-259209 | Film No.: 211227608
SIC: 2834 Pharmaceutical Preparations